Phase I trial of granulocyte-macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks: a Cancer and Leukemia Group B study.

Lichtman, S M

Phase I trial of granulocyte-macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks: a Cancer and Leukemia Group B study. [electronic resource] - Journal of the National Cancer Institute Aug 1993 - 1319-26 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0027-8874

10.1093/jnci/85.16.1319 doi


Adult
Aged
Blood Cell Count--drug effects
Bone Marrow Diseases--chemically induced
Cyclophosphamide--administration & dosage
Drug Administration Schedule
Female
Granulocyte-Macrophage Colony-Stimulating Factor--therapeutic use
Humans
Male
Middle Aged
Neoplasms--drug therapy